drugset / Trial / NCT02199873
Safety, Tolerability and Pharmacodynamics of BIIX 1 XX in Healthy Young Male Volunteers
RandomizedSingle-groupDouble-blindTreatment
Summary
The objective of the present study is to obtain information about the safety and tolerability of BIIX 1 XX, to determine the pharmacologically active dose (range) by performing a methacholine challenge test and to obtain preliminary pharmacokinetic data
Timeline
- Start
- 1998-06
- Primary completion
- 1998-09
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BIIX 1 XX | Unknown | 5 ug | Inhaled |
| Subject | BIIX 1 XX | Unknown | 800 ug | Inhaled |
Indications
No indication recorded.